Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1999 1
2000 2
2002 5
2003 2
2004 1
2005 1
2006 2
2007 2
2009 2
2010 1
2011 4
2012 6
2013 8
2014 4
2015 5
2016 7
2017 5
2018 8
2019 6
2020 12
2021 19
2022 7
2023 10
2024 13
2025 18
2026 1

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

134 results

Results by year

Filters applied: . Clear all
Page 1
Update of penetrance estimates in Birt-Hogg-Dubé syndrome.
Bruinsma FJ, Dowty JG, Win AK, Goddard LC, Agrawal P, Attina' D, Bissada N, De Luise M, Eisen DB, Furuya M, Gasparre G, Genuardi M, Gerdes AM, Hansen TVO, Houweling AC, Johannesma PC, Lencastre A, Lim D, Lindor NM, Luzzi V, Lynch M, Maffé A, Menko FH, Michels G, Pulido JS, Ryu JH, Sattler EC, Steinlein OK, Tomassetti S, Tucker K, Turchetti D, van de Beek I, van Riel L, van Steensel M, Zenone T, Zompatori M, Walsh J, Bondavalli D, Maher ER, Winship IM; Genetic Susceptibility Working Group I-CONFIRM. Bruinsma FJ, et al. Among authors: turchetti d. J Med Genet. 2023 Apr;60(4):317-326. doi: 10.1136/jmg-2022-109104. Epub 2023 Feb 27. J Med Genet. 2023. PMID: 36849229 Review.
Parp-inhibitors in the therapeutic landscape of breast cancer patients with BRCA1 and BRCA2 pathogenic germline variants: An Italian consensus paper and critical review.
Zambelli A, Cortesi L, Gaudio M, Arpino G, Bianchini G, Caruso F, Cinieri S, Curigliano G, Del Mastro L, De Placido S, Fabi A, Fortunato L, Generali D, Gennari A, Gori S, Grandi G, Guarneri V, Klinger M, Livi L, Marchiò C, Palumbo I, Panizza P, Pravettoni G, Pruneri G, Puglisi F, Sapino A, Tinterri C, Turchetti D, De Laurentiis M. Zambelli A, et al. Among authors: turchetti d. Cancer Treat Rev. 2024 Nov;130:102815. doi: 10.1016/j.ctrv.2024.102815. Epub 2024 Aug 21. Cancer Treat Rev. 2024. PMID: 39208751 Free article. Review.
The risk of a second primary cancer in PTEN Hamartoma Tumor Syndrome (PHTS).
Hendricks LAJ, Verbeek KCJ, Schuurs-Hoeijmakers JHM, de Jong MM, Links TP, Brems H, Aerden M, Brunet J, Lleuger-Pujol R, Hüneburg R, Aretz S, Colas C, Villy MC, Woodward ER, Evans DG, Bosch DGM, Donze SH, Foretová L, Blatnik A, Leter EM, Tischkowitz M, Jahn A, de Putter R, Dupont J, Briskemyr S, Steinke-Lange V, Baldassarri M, Anastasiadou VC, Irmejs A, Oliveira C, van der Post RS, Mensenkamp AR, Tesi B, Mu N, Benusiglio PR, Gerasimenko A, Innella G, Turchetti D, Houdayer C, Branchaud M, Høberg Vetti H, Tveit Haavind M, Balmaña J, Torres M, Genuardi M, Panfili A, Jørgensen K, Mæhle L, Hoogerbrugge N, Vos JR. Hendricks LAJ, et al. Among authors: turchetti d. Genet Med. 2025 Oct;27(10):101467. doi: 10.1016/j.gim.2025.101467. Epub 2025 May 24. Genet Med. 2025. PMID: 40433764 Free article.
PREDICTIVE BRCA GENETIC TESTING IN ITALIAN PATIENTS WITH BREAST CANCER: A POSITION PAPER OF ITALIAN SCIENTIFIC SOCIETIES [Italian Association of Medical Oncology(AIOM); Italian Association of Radiotherapy and Clinical Oncology (AIRO); Italian National Association of Breast Surgeons (ANISC); Italian Society of Pathological Anatomy and Diagnostic Cytology (SIAPeC-IAP); Italian Society of Surgical Oncology (SICO); Italian Society of Human Genetic (SIGU); Italian Society of General Practice (SIMG); Italian Society of Medical and Interventional Radiology (SIRM)].
Cortesi L, Miglietta F, Arecco L, Bernardi D, Biganzoli L, Del Mastro L, Dieci MV, Foglietta J, Fortunato L, Franco P, Cordisco EL, Mantellini P, Marchio' C, Meduri B, Micallo G, Musolino A, Salvetti A, Turchetti D, Zambelli A, Angiolini C, Cinieri S, Conte PF, Curigliano G, Dessena M, Fabi A, Leonardi MC, Meattini I, Montemezzi S, Puglisi F, Sapino A, Taffurelli M, Cinquini M, Gori S. Cortesi L, et al. Among authors: turchetti d. Cancer Treat Rev. 2025 Sep;139:102976. doi: 10.1016/j.ctrv.2025.102976. Epub 2025 Jun 15. Cancer Treat Rev. 2025. PMID: 40543108 Free article. Review.
BRCA2 in Ovarian Development and Function.
Turchetti D, Zuntini R, Tricarico R, Bellacosa A. Turchetti D, et al. N Engl J Med. 2019 Mar 14;380(11):1086-1087. doi: 10.1056/NEJMc1813800. N Engl J Med. 2019. PMID: 30865813 No abstract available.
BRCA-associated ovarian cancer: from molecular genetics to risk management.
Girolimetti G, Perrone AM, Santini D, Barbieri E, Guerra F, Ferrari S, Zamagni C, De Iaco P, Gasparre G, Turchetti D. Girolimetti G, et al. Among authors: turchetti d. Biomed Res Int. 2014;2014:787143. doi: 10.1155/2014/787143. Epub 2014 Jul 22. Biomed Res Int. 2014. PMID: 25136623 Free PMC article. Review.
Atypical cancer risk profile in carriers of Italian founder BRCA1 variant p.His1673del: Implications for classification and clinical management.
Innella G, Fortuno C, Caleca L, Feng BJ, Carroll C, Parsons MT, Miccoli S, Montagna M, Calistri D, Cortesi L, Pasini B, Manoukian S, Giachino D, Matricardi L, Foti MC, Zampiga V, Piombino C, Barbieri E, Lutati FV, Azzolini J, Danesi R, Arcangeli V, Caputo SM, Boutry-Kryza N, Goussot V, Hiraki S, Richardson M; Hereditary Breast/Ovarian Cancer IOV network (HBOC IOVnet); Ferrari S, Radice P, Spurdle AB, Turchetti D. Innella G, et al. Among authors: turchetti d. Cancer Med. 2024 Aug;13(16):e70114. doi: 10.1002/cam4.70114. Cancer Med. 2024. PMID: 39194334 Free PMC article.
134 results